Search research articles
Contact Us
Filters
Showing results (221-230 of 267) with videos related to
Page
of 27
Sort By:
Eclinicalmedicine
|
March 14, 2023
Optimising the dosage of ready-to-use therapeutic food in children with uncomplicated severe acute malnutrition in the Democratic Republic of the Congo: a non-inferiority, randomised controlled trial
Cécile Cazes, Kevin Phelan, Victoire Hubert, et al.
The Lancet. Global Health
|
March 18, 2022
Simplifying and optimising the management of uncomplicated acute malnutrition in children aged 6-59 months in the Democratic Republic of the Congo (OptiMA-DRC): a non-inferiority, randomised controlled trial
Cécile Cazes, Kevin Phelan, Victoire Hubert, et al.
Journal of Adolescent and Young Adult Oncology
|
August 15, 2019
Pattern of Care and Outcomes of Adolescent and Young Adults with Lymphoma Treated in the Rhône-Alpes Region
Arthur Dony, Amine Belhabri, Yves Bertrand, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)
|
October 19, 2020
Association of Plasma Soluble Vascular Cell Adhesion Molecule-1 and sCD14 With Mortality in HIV-1-Infected West African Adults With High CD4 Counts
Roseline Affi, Delphine Gabillard, Catherine Dunyach-Remy, et al.
The Lancet. HIV
|
January 2, 2021
Isoniazid preventive therapy plus antiretroviral therapy for the prevention of tuberculosis: a systematic review and meta-analysis of individual participant data
Jennifer M Ross, Anani Badje, Molebogeng X Rangaka, et al.
Open Forum Infectious Diseases
|
December 21, 2022
Determinants of Antiretroviral Treatment Success and Adherence in People With Human Immunodeficiency Virus Treated for Tuberculosis
Nathalie De Castro, Corine Chazallon, Jean-Baptiste N'takpe, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)
|
January 1, 2013
Mortality, AIDS-morbidity, and loss to follow-up by current CD4 cell count among HIV-1-infected adults receiving antiretroviral therapy in Africa and Asia: data from the ANRS 12222 collaboration
Delphine Gabillard, Charlotte Lewden, Ibra Ndoye, et al.
Leukemia & Lymphoma
|
April 12, 2017
A phase II Bayesian sequential clinical trial in advanced Waldenström macroglobulinemia patients treated with bortezomib: interest of addition of dexamethasone
Véronique Leblond, Pierre Morel, Marie-Sarah Dilhuidy, et al.
British Journal of Haematology
|
August 18, 2018
Bendamustine and rituximab in elderly patients with low-tumour burden follicular lymphoma. Results of the LYSA phase II BRIEF study
Emmanuel Gyan, Anne Sonet, Pauline Brice, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
December 14, 2012
Phase III study of ACVBP versus ACVBP plus rituximab for patients with localized low-risk diffuse large B-cell lymphoma (LNH03-1B)
N Ketterer, B Coiffier, C Thieblemont, et al.
Page
of 27
Search research articles
Search
Showing results (221-230 of 267) with videos related to
Sort By:
Page
of 27
Eclinicalmedicine
|
March 14, 2023
Optimising the dosage of ready-to-use therapeutic food in children with uncomplicated severe acute malnutrition in the Democratic Republic of the Congo: a non-inferiority, randomised controlled trial
Cécile Cazes, Kevin Phelan, Victoire Hubert, et al.
The Lancet. Global Health
|
March 18, 2022
Simplifying and optimising the management of uncomplicated acute malnutrition in children aged 6-59 months in the Democratic Republic of the Congo (OptiMA-DRC): a non-inferiority, randomised controlled trial
Cécile Cazes, Kevin Phelan, Victoire Hubert, et al.
Journal of Adolescent and Young Adult Oncology
|
August 15, 2019
Pattern of Care and Outcomes of Adolescent and Young Adults with Lymphoma Treated in the Rhône-Alpes Region
Arthur Dony, Amine Belhabri, Yves Bertrand, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)
|
October 19, 2020
Association of Plasma Soluble Vascular Cell Adhesion Molecule-1 and sCD14 With Mortality in HIV-1-Infected West African Adults With High CD4 Counts
Roseline Affi, Delphine Gabillard, Catherine Dunyach-Remy, et al.
The Lancet. HIV
|
January 2, 2021
Isoniazid preventive therapy plus antiretroviral therapy for the prevention of tuberculosis: a systematic review and meta-analysis of individual participant data
Jennifer M Ross, Anani Badje, Molebogeng X Rangaka, et al.
Open Forum Infectious Diseases
|
December 21, 2022
Determinants of Antiretroviral Treatment Success and Adherence in People With Human Immunodeficiency Virus Treated for Tuberculosis
Nathalie De Castro, Corine Chazallon, Jean-Baptiste N'takpe, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)
|
January 1, 2013
Mortality, AIDS-morbidity, and loss to follow-up by current CD4 cell count among HIV-1-infected adults receiving antiretroviral therapy in Africa and Asia: data from the ANRS 12222 collaboration
Delphine Gabillard, Charlotte Lewden, Ibra Ndoye, et al.
Leukemia & Lymphoma
|
April 12, 2017
A phase II Bayesian sequential clinical trial in advanced Waldenström macroglobulinemia patients treated with bortezomib: interest of addition of dexamethasone
Véronique Leblond, Pierre Morel, Marie-Sarah Dilhuidy, et al.
British Journal of Haematology
|
August 18, 2018
Bendamustine and rituximab in elderly patients with low-tumour burden follicular lymphoma. Results of the LYSA phase II BRIEF study
Emmanuel Gyan, Anne Sonet, Pauline Brice, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
December 14, 2012
Phase III study of ACVBP versus ACVBP plus rituximab for patients with localized low-risk diffuse large B-cell lymphoma (LNH03-1B)
N Ketterer, B Coiffier, C Thieblemont, et al.
Page
of 27